A noninvasive method for assessing PNST tumor risk in patients with NF1
NCI Center for Cancer Research shared a post on LinkedIn:
“Featured by National Institutes of Health (NIH): Intramural Research Program (IRP): Neurofibromatosis type 1 (NF1) is a genetic disorder of deregulated cell growth. People with NF1 are at an increased risk of developing a variety of tumors, including peripheral nerve sheath tumors (PNSTs), which can grow along nerves and be malignant.
A team of researchers from CCR’s Pediatric Oncology Branch, alongside extramural collaborators, have developed a noninvasive method for assessing PNST tumor risk in patients with NF1.
Image description: ‘The inherited condition neurofibromatosis type 1 is caused by changes in a gene called NF1, which is found on chromosome 17. Credit: DermNetNZ CC BY-NC-ND 3.0 NZ’. ”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023